Analyte Antibodies

PGI Antibodies

LFA, TIAResearch Grade
Catalog No. A28190Available — Request a Quote

Target-specific antibody reagent for assay development, optimization and analytical evaluation involving PGI. Pepsinogen-I target for gastric-mucosal-atrophy and pepsinogen-panel assay development.

Product Type

Antibodies & Antigens

Sub-Category

Analyte Antibodies

Platform

LFA, TIA

Application

GI

01

Overview

Target-specific antibody reagent for assay development, optimization and analytical evaluation involving PGI. Pepsinogen-I target for gastric-mucosal-atrophy and pepsinogen-panel assay development.

Target-specific antibody reagent for assay development, optimization and analytical evaluation involving PGI. Pepsinogen-I target for gastric-mucosal-atrophy and pepsinogen-panel assay development. Serum pepsinogen I and the PGI/PGII ratio are noninvasive markers associated with gastric mucosal atrophy and have been studied in gastric-cancer risk/screening strategies, with substantial method/population heterogeneity.

Professional Context

Serum pepsinogen I and the PGI/PGII ratio are noninvasive markers associated with gastric mucosal atrophy and have been studied in gastric-cancer risk/screening strategies, with substantial method/population heterogeneity.

02

Technical Specifications

Antibody Information

Target

PGI

Technology Platform

Lateral Flow & Colloidal Gold

Application Tags

GI

Storage

2~8℃

Shelf Life

2年; 3年

Sample Pack

2mg; 1mg

03

Technical Resources

Technical Resources

Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.

Need to confirm the right product or material for your project?

Our technical team can assist with product selection, provide samples, and support your IVD development project.